359 related articles for article (PubMed ID: 32822775)
1. Tocilizumab improves oxidative stress and endothelial glycocalyx: A mechanism that may explain the effects of biological treatment on COVID-19.
Ikonomidis I; Pavlidis G; Katsimbri P; Lambadiari V; Parissis J; Andreadou I; Tsoumani M; Boumpas D; Kouretas D; Iliodromitis E
Food Chem Toxicol; 2020 Nov; 145():111694. PubMed ID: 32822775
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of inhibition of interleukin 1 and 6 on myocardial, coronary and vascular function.
Ikonomidis I; Pavlidis G; Katsimbri P; Andreadou I; Triantafyllidi H; Tsoumani M; Varoudi M; Vlastos D; Makavos G; Kostelli G; Βenas D; Lekakis J; Parissis J; Boumpas D; Alexopoulos D; Iliodromitis E
Clin Res Cardiol; 2019 Oct; 108(10):1093-1101. PubMed ID: 30859382
[TBL] [Abstract][Full Text] [Related]
3. Association of COVID-19 with impaired endothelial glycocalyx, vascular function and myocardial deformation 4 months after infection.
Lambadiari V; Mitrakou A; Kountouri A; Thymis J; Katogiannis K; Korakas E; Varlamos C; Andreadou I; Tsoumani M; Triantafyllidi H; Bamias A; Thomas K; Kazakou P; Grigoropoulou S; Kavatha D; Antoniadou A; Dimopoulos MA; Ikonomidis I
Eur J Heart Fail; 2021 Nov; 23(11):1916-1926. PubMed ID: 34415085
[TBL] [Abstract][Full Text] [Related]
4. Impaired Arterial Elastic Properties and Endothelial Glycocalyx in Patients with Embolic Stroke of Undetermined Source.
Ikonomidis I; Frogoudaki A; Vrettou AR; Andreou I; Palaiodimou L; Katogiannis K; Liantinioti C; Vlastos D; Zervas P; Varoudi M; Lambadiari V; Triantafyllidi H; Pavlidis G; Efentakis P; Tsoumani M; Tsantes AE; Parissis J; Revela I; Andreadou I; Tsivgoulis G
Thromb Haemost; 2019 Nov; 119(11):1860-1868. PubMed ID: 31421641
[TBL] [Abstract][Full Text] [Related]
5. Effects of varenicline and nicotine replacement therapy on arterial elasticity, endothelial glycocalyx and oxidative stress during a 3-month smoking cessation program.
Ikonomidis I; Marinou M; Vlastos D; Kourea K; Andreadou I; Liarakos N; Triantafyllidi H; Pavlidis G; Tsougos E; Parissis J; Lekakis J
Atherosclerosis; 2017 Jul; 262():123-130. PubMed ID: 28549278
[TBL] [Abstract][Full Text] [Related]
6. Effects of Different Antidiabetic Medications on Endothelial Glycocalyx, Myocardial Function, and Vascular Function in Type 2 Diabetic Patients: One Year Follow-Up Study.
Lambadiari V; Pavlidis G; Kousathana F; Maratou E; Georgiou D; Andreadou I; Kountouri A; Varoudi M; Balampanis K; Parissis J; Triantafyllidi H; Katogiannis K; Birba D; Lekakis J; Dimitriadis G; Ikonomidis I
J Clin Med; 2019 Jul; 8(7):. PubMed ID: 31284526
[TBL] [Abstract][Full Text] [Related]
7. Early detection of left ventricular dysfunction in first-degree relatives of diabetic patients by myocardial deformation imaging: The role of endothelial glycocalyx damage.
Ikonomidis I; Pavlidis G; Lambadiari V; Kousathana F; Varoudi M; Spanoudi F; Maratou E; Parissis J; Triantafyllidi H; Dimitriadis G; Lekakis J
Int J Cardiol; 2017 Apr; 233():105-112. PubMed ID: 28096045
[TBL] [Abstract][Full Text] [Related]
8. Endothelial glycocalyx and microvascular perfusion are associated with carotid intima-media thickness and impaired myocardial deformation in psoriatic disease.
Ikonomidis I; Pavlidis G; Lambadiari V; Rafouli-Stergiou P; Makavos G; Thymis J; Kostelli G; Varoudi M; Katogiannis K; Theodoropoulos K; Katsimbri P; Parissis J; Papadavid E
J Hum Hypertens; 2022 Dec; 36(12):1113-1120. PubMed ID: 34819613
[TBL] [Abstract][Full Text] [Related]
9. Apremilast Improves Endothelial Glycocalyx Integrity, Vascular and Left Ventricular Myocardial Function in Psoriasis.
Ikonomidis I; Pavlidis G; Kadoglou N; Makavos G; Katogiannis K; Kountouri A; Thymis J; Kostelli G; Kapniari I; Theodoropoulos K; Parissis J; Katsimbri P; Papadavid E; Lambadiari V
Pharmaceuticals (Basel); 2022 Jan; 15(2):. PubMed ID: 35215285
[TBL] [Abstract][Full Text] [Related]
10. Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial.
Dastan F; Saffaei A; Haseli S; Marjani M; Moniri A; Abtahian Z; Abedini A; Kiani A; Seifi S; Jammati H; Hashemian SMR; Pourabdollah Toutkaboni M; Eslaminejad A; Heshmatnia J; Sadeghi M; Nadji SA; Dastan A; Baghaei P; Varahram M; Yousefian S; Salamzadeh J; Tabarsi P
Int Immunopharmacol; 2020 Nov; 88():106869. PubMed ID: 32889241
[TBL] [Abstract][Full Text] [Related]
11. Association of impaired endothelial glycocalyx with arterial stiffness, coronary microcirculatory dysfunction, and abnormal myocardial deformation in untreated hypertensives.
Ikonomidis I; Voumvourakis A; Makavos G; Triantafyllidi H; Pavlidis G; Katogiannis K; Benas D; Vlastos D; Trivilou P; Varoudi M; Parissis J; Iliodromitis E; Lekakis J
J Clin Hypertens (Greenwich); 2018 Apr; 20(4):672-679. PubMed ID: 29498204
[TBL] [Abstract][Full Text] [Related]
12. Vascular conditioning prevents adverse left ventricular remodelling after acute myocardial infarction: a randomised remote conditioning study.
Ikonomidis I; Vlastos D; Andreadou I; Gazouli M; Efentakis P; Varoudi M; Makavos G; Kapelouzou A; Lekakis J; Parissis J; Katsanos S; Tsilivarakis D; Hausenloy DJ; Alexopoulos D; Cokkinos DV; Bøtker HE; Iliodromitis EK
Basic Res Cardiol; 2021 Feb; 116(1):9. PubMed ID: 33547969
[TBL] [Abstract][Full Text] [Related]
13. Outcome of COVID-19 patients with use of Tocilizumab: A single center experience.
Zain Mushtaq M; Bin Zafar Mahmood S; Jamil B; Aziz A; Ali SA
Int Immunopharmacol; 2020 Nov; 88():106926. PubMed ID: 32889236
[TBL] [Abstract][Full Text] [Related]
14. Infliximab equivalently suppresses oxidative stress compared to tocilizumab among well-controlled patients with rheumatoid arthritis.
Kizaki K; Yamashita F; Hayashi T; Funakoshi N
Int J Rheum Dis; 2018 Oct; 21(10):1815-1821. PubMed ID: 27778459
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 receptor antagonist therapy to treat SARS-CoV-2 driven inflammatory syndrome in a kidney transplant recipient.
Allam SR; Dao A; Madhrira MM; Antiporta PB; Nair RR; Guiteau JJ; Reyad AI
Transpl Infect Dis; 2020 Aug; 22(4):e13326. PubMed ID: 32406985
[No Abstract] [Full Text] [Related]
16. A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab.
Cai S; Sun W; Li M; Dong L
Clin Rheumatol; 2020 Sep; 39(9):2797-2802. PubMed ID: 32562070
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 6-blockade treatment for severe COVID-19 in two patients with multiple myeloma.
Chaidos A; Katsarou A; Mustafa C; Milojkovic D; Karadimitris A
Br J Haematol; 2020 Jul; 190(1):e9-e11. PubMed ID: 32369612
[No Abstract] [Full Text] [Related]
18. The Combined Use of Tocilizumab and Hemoadsorption in a Patient with SARS-COV-2-19-Associated Pneumonia: A Case Report.
Berlot G; Tomasini A; Roman Pognuz E; Randino A; Chiella F; La Fata C; Piva M; Amato P; di Maso V; Bianco F; Gerini U; Tomietto P; Trenti T
Nephron; 2020; 144(9):459-462. PubMed ID: 32694244
[TBL] [Abstract][Full Text] [Related]
19. The differential response to anti IL-6 treatment in COVID-19: the genetic counterpart.
Perricone C; Conigliaro P; Ciccacci C; Marcucci E; Cafaro G; Bartoloni E; Perricone R; Novelli G; Borgiani P; Gerli R
Clin Exp Rheumatol; 2020; 38(3):580. PubMed ID: 32452345
[No Abstract] [Full Text] [Related]
20. Lack of tocilizumab effect on mortality in COVID19 patients.
Holt GE; Batra M; Murthi M; Kambali S; Santos K; Bastidas MVP; Asif H; Haddadi S; Arias S; Mirsaeidi M
Sci Rep; 2020 Oct; 10(1):17100. PubMed ID: 33051534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
